| Emergence of Zaire Ebola virus disease in Guinea S Baize, D Pannetier, L Oestereich, T Rieger, L Koivogui, ... New England Journal of Medicine 371 (15), 1418-1425, 2014 | 1864 | 2014 |
| Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model L Oestereich, A Lüdtke, S Wurr, T Rieger, C Muñoz-Fontela, S Günther Antiviral research 105, 17-21, 2014 | 627 | 2014 |
| Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015 | 370 | 2015 |
| Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications L Zammarchi, G Stella, A Mantella, D Bartolozzi, D Tappe, S Günther, ... Journal of Clinical Virology 63, 32-35, 2015 | 280 | 2015 |
| Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak LE Kafetzopoulou, ST Pullan, P Lemey, MA Suchard, DU Ehichioya, ... Science 363 (6422), 74-77, 2019 | 249 | 2019 |
| Unique human immune signature of Ebola virus disease in Guinea P Ruibal, L Oestereich, A Lüdtke, B Becker-Ziaja, DM Wozniak, R Kerber, ... Nature 533 (7601), 100-104, 2016 | 180 | 2016 |
| Entry of bunyaviruses into mammalian cells PY Lozach, R Mancini, D Bitto, R Meier, L Oestereich, AK Överby, ... Cell host & microbe 7 (6), 488-499, 2010 | 177 | 2010 |
| Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever L Oestereich, T Rieger, M Neumann, C Bernreuther, M Lehmann, ... PLoS neglected tropical diseases 8 (5), e2804, 2014 | 173 | 2014 |
| Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study D Sissoko, S Duraffour, R Kerber, JS Kolie, AH Beavogui, AM Camara, ... The Lancet Global Health 5 (1), e80-e88, 2017 | 130 | 2017 |
| Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever L Oestereich, T Rieger, A Lüdtke, P Ruibal, S Wurr, E Pallasch, S Bockholt, ... The Journal of infectious diseases 213 (6), 934-938, 2016 | 123 | 2016 |
| Ebola virus dynamics in mice treated with favipiravir V Madelain, L Oestereich, F Graw, THT Nguyen, X De Lamballerie, ... Antiviral research 123, 70-77, 2015 | 78 | 2015 |
| Favipiravir pharmacokinetics in nonhuman primates and insights for future efficacy studies of hemorrhagic fever viruses V Madelain, J Guedj, F Mentré, THT Nguyen, F Jacquot, L Oestereich, ... Antimicrobial agents and chemotherapy 61 (1), 10.1128/aac. 01305-16, 2017 | 73 | 2017 |
| Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin P Emmerich, C Murawski, C Ehmen, R von Possel, N Pekarek, ... Tropical medicine & international health 26 (6), 621-631, 2021 | 67 | 2021 |
| Phylogeography of Lassa virus in Nigeria DU Ehichioya, S Dellicour, M Pahlmann, T Rieger, L Oestereich, ... Journal of virology 93 (21), 10.1128/jvi. 00929-19, 2019 | 64 | 2019 |
| Determining Ribavirin’s mechanism of action against Lassa virus infection P Carrillo-Bustamante, THT Nguyen, L Oestereich, S Günther, J Guedj, ... Scientific reports 7 (1), 11693, 2017 | 60 | 2017 |
| Gairo virus, a novel arenavirus of the widespread Mastomys natalensis: Genetically divergent, but ecologically similar to Lassa and Morogoro viruses S Gryseels, T Rieger, L Oestereich, B Cuypers, B Borremans, R Makundi, ... Virology 476, 249-256, 2015 | 51 | 2015 |
| Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections E Cimini, D Viola, M Cabeza-Cabrerizo, A Romanelli, N Tumino, A Sacchi, ... PLoS Neglected Tropical Diseases 11 (5), e0005645, 2017 | 49 | 2017 |
| Chimeric mice with competent hematopoietic immunity reproduce key features of severe Lassa fever L Oestereich, A Lüdtke, P Ruibal, E Pallasch, R Kerber, T Rieger, S Wurr, ... PLoS pathogens 12 (5), e1005656, 2016 | 49 | 2016 |
| Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR F Olearo, D Nörz, F Heinrich, JP Sutter, K Roedl, A Schultze, ... Journal of Clinical Virology 137, 104782, 2021 | 46 | 2021 |
| Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol C Müller, W Obermann, FW Schulte, K Lange-Grünweller, L Oestereich, ... Antiviral Research 175, 104706, 2020 | 46 | 2020 |
